Company Filing History:
1 out of 6 
1 out of 30 Years Active: 2012
Title: Sarl Tiitinen: Innovator in Stem Cell Research
Introduction
Sarl Tiitinen is a notable inventor based in Vantaa, Finland. He has made significant contributions to the field of stem cell research, particularly through his innovative patent that addresses the evaluation of cell populations. His work focuses on the intricate relationship between sialylation and stem cell status, which has important implications for biological materials and contamination control.
Latest Patents
Sarl Tiitinen holds a patent titled "Method for evaluating cell populations." This invention describes specific sialylated structures present on human stem cells and cell populations derived from them. The patent outlines methods to control the status of stem cells by observing changes in sialylation. It also addresses the control of potential contaminations of biological materials and the reagents used in connection with the cells to avoid alterations in cell glycosylation caused by contaminating materials. Additionally, the invention introduces novel stem cells with specifically altered glycosylation.
Career Highlights
Throughout his career, Sarl Tiitinen has worked with various organizations, including the Finnish Red Cross Blood Service and Glykos Finland Oy. His experience in these companies has allowed him to apply his research in practical settings, contributing to advancements in the field of biotechnology and stem cell applications.
Collaborations
Sarl Tiitinen has collaborated with notable colleagues such as Jarmo Laine and Taina Jaatinen. These partnerships have fostered a collaborative environment that enhances research and innovation in stem cell technology.
Conclusion
Sarl Tiitinen's contributions to stem cell research through his patent and collaborations highlight his role as an innovator in the field. His work not only advances scientific understanding but also has practical applications in biotechnology.